(Q22009110)

English

Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells

scientific article

In more languages

Statements

scholarly article

0 references

Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

G Xiao

1

author given names

G

author last names

Xiao

1 reference

PubMed publication ID

6 February 2023

Y E Liu

2

author given names

Y E

author last names

Liu

1 reference

PubMed publication ID

6 February 2023

R Gentz

3

author given names

R

author last names

Gentz

1 reference

PubMed publication ID

6 February 2023

Q A Sang

4

author given names

Q A

author last names

Sang

1 reference

PubMed publication ID

6 February 2023

J Ni

5

author given names

J

author last names

Ni

1 reference

PubMed publication ID

6 February 2023

I D Goldberg

6

author given names

I D

author last names

Goldberg

1 reference

PubMed publication ID

6 February 2023

Y E Shi

7

author given names

Y E

author last names

Shi

1 reference

PubMed publication ID

6 February 2023

language of work or name

0 references

publication date

30 March 1999

0 references

Proceedings of the National Academy of Sciences of the United States of America

0 references

96

0 references

7

0 references

3700-5

0 references

Basic local alignment search tool

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

19 March 2017

Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

19 March 2017

Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

19 March 2017

Complementary DNA sequencing: expressed sequence tags and human genome project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

7 April 2017

Plasminogen activator inhibitor type 2 in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Purification, cDNA cloning, and characterization of a new serpin with megakaryocyte maturation activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

12 September 2017

Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

27 September 2017

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

27 September 2017

Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

27 September 2017

Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

27 September 2017

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Differentiation of breast cancer cells in vitro is promoted by the concurrent influence of myoepithelial cells and relaxin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

30 May 2018

Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.96.7.3700

21 January 2018

Incidence of and treatment for ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.96.7.3700

21 January 2018

Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=22357

29 November 2018

Plasminogen activator system in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Function of maspin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The myoepithelial defense: a host defense against cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteases as prognostic markers in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10097100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.96.7.3700

0 references

1999PNAS...96.3700X

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q22009110&oldid=1827986850"